Kinross Gold Corporation (NYSE:KGC) has been given a consensus recommendation of “Hold” by the seventeen brokerages that are currently covering the company, AnalystRatingsNetwork reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $4.56. Kinross Gold Corporation (NYSE:KGC) in last trading activity advanced 0.71% to close at $2.82. Company weekly performance is 8.88% while its quarterly performance stands at -13.50%. Kinross Gold Corporation (NYSE:KGC) is -48.16% away from its 52 week high.
Calpine Corporation (NYSE:CPN) is looking to increase plant capacities in Pennsylvania, Texas and Minnesota to increase generation capacity by about 1,500 megawatts (MW) by the spring of 2018. On last trading day Calpine Corp. (NYSE:CPN) decreased -0.81% to close at $22.13. Its volatility for the week is 2.05% while volatility for the month is 2.45%. CPN’s sales growth for past 5 years was -8.50% and its EPS growth for past 5 years was 21.10%. Calpine Corp. (NYSE:CPN) monthly performance is -1.51%.
Peabody Energy Corp. (NYSE:BTU) Director Michael W. Sutherlin purchased 5,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, December 15th. The shares were purchased at an average cost of $7.26 per share, with a total value of $36,300.00. Peabody Energy Corp. (NYSE:BTU) has 0.10% insider ownership while its institutional ownership stands at 99.70%. In last trading activity company’s stock closed at $7.74.
On December 11, 2014, Mr. Scott T. Sutton, who has served as Executive Vice President and Chief Operations Officer of Home Bancorp, Inc. (NASDAQ:HBCP) and its wholly owned subsidiary, Home Bank (the “Bank”), since August 2008, announced his retirement effective as of January 15, 2015.On Wednesday shares of Home Bancorp, Inc. (NASDAQ:HBCP) closed at $22.94. Company’s sales growth for last 5 years was 9.80%.
NxStage Medical (NASDAQ:NXTM) President Joseph E. Turk, Jr. unloaded 2,350 shares of the company’s stock on the open market in a transaction dated Tuesday, December 23rd. The stock was sold at an average price of $18.44, for a total transaction of $43,334.00. Following the completion of the transaction, the president now directly owns 111,947 shares in the company, valued at approximately $2,064,303. On last trading day Nxstage Medical, Inc. (NASDAQ:NXTM) decreased -1.65% to close at $17.93. Its volatility for the week is 2.83% while volatility for the month is 4.25%. NXTM’s sales growth for past 5 years was 15.40% and its EPS growth for past 5 years was 24.10%. Nxstage Medical, Inc. (NASDAQ:NXTM) monthly performance is 4.24%.